• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑实质型囊尾蚴病抗囊尾蚴药物治疗方案的比较

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

作者信息

Sotelo J, del Brutto O H, Penagos P, Escobedo F, Torres B, Rodriguez-Carbajal J, Rubio-Donnadieu F

机构信息

National Institute of Neurology and Neurosurgery of Mexico.

出版信息

J Neurol. 1990 Apr;237(2):69-72. doi: 10.1007/BF00314663.

DOI:10.1007/BF00314663
PMID:2192018
Abstract

The efficacy of different regimens of therapy for parenchymal brain cysticercosis either with praziquantel (PZQ) or with albendazole (ALB) was compared in 114 patients. Four schemes of treatment were used: PZQ 50 mg/kg per day for 15 days, PZQ 50 mg/kg per day for 8 days, ALB 15 mg/kg per day for 30 days, and ALB 15 mg/kg per day for 8 days. Three months after therapy, it was apparent that both PZQ and ALB were effective, as shown by the disappearance of cystic lesions in computed tomographic scans. Thirty-three control patients followed for a mean of 11 months had no spontaneous remission of lesions. When comparing PZQ with ALB, the latter was found to be more effective than the former for both the full and the short course of treatment: 85% vs 60% and 85% vs 48% disappearance of lesions, respectively (P less than 0.001). Comparison of the full vs the short course of PZQ showed that the short course had a further 12% reduction in drug effectiveness. In contrast, the length of ALB therapy could be shortened without lessening its efficacy. Based on these results, an 8-day course of ALB is recommended as treatment for parenchymal brain cysticercosis; a 15-day course of PZQ could be subsequently used in those patients who show only partial response to ALB.

摘要

对114例脑实质型囊尾蚴病患者比较了使用吡喹酮(PZQ)或阿苯达唑(ALB)的不同治疗方案的疗效。采用了四种治疗方案:PZQ每日50mg/kg,共15天;PZQ每日50mg/kg,共8天;ALB每日15mg/kg,共30天;ALB每日15mg/kg,共8天。治疗三个月后,计算机断层扫描显示囊性病变消失,表明PZQ和ALB均有效。33例对照患者平均随访11个月,病变无自发缓解。比较PZQ和ALB时,发现后者在全疗程和短疗程治疗中均比前者更有效:病变消失率分别为85%对60%和85%对48%(P<0.001)。比较PZQ的全疗程和短疗程发现,短疗程的药物有效性进一步降低了12%。相反,ALB治疗疗程可以缩短而不降低其疗效。基于这些结果,推荐8天疗程的ALB作为脑实质型囊尾蚴病的治疗方法;对于那些对ALB仅部分反应的患者,随后可使用15天疗程的PZQ。

相似文献

1
Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.脑实质型囊尾蚴病抗囊尾蚴药物治疗方案的比较
J Neurol. 1990 Apr;237(2):69-72. doi: 10.1007/BF00314663.
2
Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial.
Arch Neurol. 1988 May;45(5):532-4. doi: 10.1001/archneur.1988.00520290064015.
3
Albendazole therapy for neurocysticercosis.阿苯达唑治疗神经囊尾蚴病。
Arch Intern Med. 1987 Apr;147(4):738-41.
4
Therapy for neurocysticercosis. Comparison between albendazole and praziquantel.神经囊尾蚴病的治疗。阿苯达唑与吡喹酮的比较。
Arch Neurol. 1992 Mar;49(3):290-4. doi: 10.1001/archneur.1992.00530270106026.
5
Therapy of parenchymal brain cysticercosis with praziquantel.吡喹酮治疗脑实质型囊尾蚴病
N Engl J Med. 1984 Apr 19;310(16):1001-7. doi: 10.1056/NEJM198404193101601.
6
[Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis].[脑囊尾蚴病病例中囊肿对吡喹酮和阿苯达唑的选择性敏感性]
Rev Neurol (Paris). 1992;148(1):58-61.
7
Neurocysticercosis. Short course of treatment with albendazole.神经囊尾蚴病。阿苯达唑短程治疗。
Arch Neurol. 1989 Nov;46(11):1231-6. doi: 10.1001/archneur.1989.00520470099034.
8
Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.吡喹酮和阿苯达唑联合治疗脑实质型囊尾蚴病的杀囊效果
Clin Infect Dis. 2016 Jun 1;62(11):1375-9. doi: 10.1093/cid/ciw134. Epub 2016 Mar 16.
9
Short course of albendazole therapy for neurocysticercosis.阿苯达唑短程疗法治疗神经囊尾蚴病
Arch Neurol. 1988 Oct;45(10):1130-3. doi: 10.1001/archneur.1988.00520340084017.
10
Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.鼠囊尾蚴病模型:感染时间和治疗时间对阿苯达唑和吡喹酮杀囊效果的影响。
Exp Parasitol. 2015 Feb;149:1-6. doi: 10.1016/j.exppara.2014.12.002. Epub 2014 Dec 8.

引用本文的文献

1
Neurocysticercosis in a Non-Endemic Region: A Retrospective Cohort Study at Sheikh Khalifa Medical City (SKMC), Abu Dhabi, UAE.非流行地区的神经囊尾蚴病:阿联酋阿布扎比哈利法医学城(SKMC)的一项回顾性队列研究
Cureus. 2025 May 30;17(5):e85082. doi: 10.7759/cureus.85082. eCollection 2025 May.
2
Albendazole and praziquantel combination versus albendazole alone in children with multiple neurocysticercosis: An open labelled randomized controlled trial.阿苯达唑与吡喹酮联合用药对比单独使用阿苯达唑治疗多发神经囊尾蚴病患儿:一项开放标签随机对照试验。
J Family Med Prim Care. 2024 Jun;13(6):2300-2304. doi: 10.4103/jfmpc.jfmpc_733_23. Epub 2024 Jun 14.
3

本文引用的文献

1
Treatment of cysticercosis with praziquantel in Colombia.在哥伦比亚用吡喹酮治疗囊尾蚴病。
Am J Trop Med Hyg. 1982 Jul;31(4):811-21. doi: 10.4269/ajtmh.1982.31.811.
2
Administration of praziquantel in neurocysticercosis.
Tropenmed Parasitol. 1982 Mar;33(1):1-4.
3
Praziquantel: a major advance in anthelminthic therapy.吡喹酮:驱虫治疗的一项重大进展。
Ann Intern Med. 1983 Aug;99(2):195-8. doi: 10.7326/0003-4819-99-2-195.
Isolated Myocysticercosis of Pectoralis Major: A Rare Case.
孤立性胸大肌囊尾蚴病:1例罕见病例
Cureus. 2024 Mar 1;16(3):e55320. doi: 10.7759/cureus.55320. eCollection 2024 Mar.
4
Top-50 cited articles on cysticercosis and neurocysticercosis.关于囊虫病和脑囊虫病的前 50 篇高引文献
Medicine (Baltimore). 2024 Mar 1;103(9):e37268. doi: 10.1097/MD.0000000000037268.
5
Revisiting extracranial cysticercosis: A rare case series of mycoparasitism affecting the cervicofacial region from an endemic zone.再探颅外囊尾蚴病:来自流行地区的累及颈面部区域的罕见真菌寄生病例系列
Natl J Maxillofac Surg. 2023 May-Aug;14(2):317-320. doi: 10.4103/njms.njms_141_22. Epub 2023 Jul 13.
6
Update on the diagnosis and management of neurocysticercosis.神经囊尾蚴病的诊断与治疗进展。
Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):296-306. doi: 10.1590/0004-282X-ANP-2022-S115.
7
Seizures Related to Neurocysticercosis and Cocaine Use.与神经囊尾蚴病和可卡因使用相关的癫痫发作
Cureus. 2022 Feb 22;14(2):e22488. doi: 10.7759/cureus.22488. eCollection 2022 Feb.
8
Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world.脑囊虫病。在世界上大多数地区,它是导致癫痫发作、癫痫和其他神经疾病的常见原因。
J Neurol Sci. 2021 Aug 15;427:117527. doi: 10.1016/j.jns.2021.117527. Epub 2021 Jun 17.
9
Anthelmintics for people with neurocysticercosis.抗寄生虫药物治疗脑囊虫病患者。
Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD000215. doi: 10.1002/14651858.CD000215.pub5.
10
Taenia solium Cysticercosis and Its Impact in Neurological Disease.猪带绦虫囊尾蚴病及其在神经疾病中的影响。
Clin Microbiol Rev. 2020 May 27;33(3). doi: 10.1128/CMR.00085-19. Print 2020 Jun 17.
4
Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel.采用地塞米松和吡喹酮双相治疗脑囊尾蚴病。
Ann Intern Med. 1983 Aug;99(2):179-81. doi: 10.7326/0003-4819-99-2-179.
5
Therapy of parenchymal brain cysticercosis with praziquantel.吡喹酮治疗脑实质型囊尾蚴病
N Engl J Med. 1984 Apr 19;310(16):1001-7. doi: 10.1056/NEJM198404193101601.
6
Praziquantel and refugee health.
JAMA. 1984 May 11;251(18):2391-2.
7
Spontaneous radiographic disappearance of cerebral cysticercosis: three cases.脑囊尾蚴病的自发影像学消退:三例报告
Neurology. 1983 Oct;33(10):1377-9. doi: 10.1212/wnl.33.10.1377.
8
Albendazole as a potential treatment for human hydatidosis.阿苯达唑作为人类包虫病的一种潜在治疗方法。
Lancet. 1983 Sep 17;2(8351):652-6. doi: 10.1016/s0140-6736(83)92533-3.
9
Praziquantel in the treatment of neurocysticercosis: long-term follow-up.吡喹酮治疗神经囊尾蚴病:长期随访
Neurology. 1985 May;35(5):752-5. doi: 10.1212/wnl.35.5.752.
10
Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases.神经囊尾蚴病:基于活动型和非活动型的新分类。753例病例研究。
Arch Intern Med. 1985 Mar;145(3):442-5.